314 related articles for article (PubMed ID: 15073141)
1. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest.
Jonard S; Dewailly D
Hum Reprod Update; 2004; 10(2):107-17. PubMed ID: 15073141
[TBL] [Abstract][Full Text] [Related]
2. Elevated ovarian pentraxin 3 in polycystic ovary syndrome.
Pan J; Zhou C; Zhou Z; Yang Z; Dai T; Huang H; Jin L
J Assist Reprod Genet; 2021 May; 38(5):1231-1237. PubMed ID: 33594624
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary rat model exposure to 150 kHz intermediate frequency: hypothalamic-pituitary-ovarian axis at the receptor, cellular, tissue, and hormone levels.
Mohammed S; Sundaram V; Adidam Venkata CR; Zyuzikov N
J Ovarian Res; 2021 Dec; 14(1):173. PubMed ID: 34895279
[TBL] [Abstract][Full Text] [Related]
4. Hyperandrogenic environment regulates the function of ovarian granulosa cells by modulating macrophage polarization in PCOS.
Chen X; Hong L; Diao L; Yin T; Liu S
Am J Reprod Immunol; 2024 May; 91(5):e13854. PubMed ID: 38716832
[TBL] [Abstract][Full Text] [Related]
5. MIF-mediated NF-κB signaling pathway regulates the pathogenesis of polycystic ovary syndrome in rats.
He Z; Wang Y; Zhuan L; Li Y; Tang ZO; Wu Z; Ma Y
Cytokine; 2021 Oct; 146():155632. PubMed ID: 34242901
[TBL] [Abstract][Full Text] [Related]
6. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.
Qiao J; Feng HL
Hum Reprod Update; 2011; 17(1):17-33. PubMed ID: 20639519
[TBL] [Abstract][Full Text] [Related]
7. A Mechanism for Ovulation Number Control.
Shilo M; Mayo A; Alon U
Front Endocrinol (Lausanne); 2022; 13():816967. PubMed ID: 35909517
[TBL] [Abstract][Full Text] [Related]
8. Involvement of androgens in ovarian health and disease.
Lebbe M; Woodruff TK
Mol Hum Reprod; 2013 Dec; 19(12):828-37. PubMed ID: 24026057
[TBL] [Abstract][Full Text] [Related]
9. Follicle dynamics and anovulation in polycystic ovary syndrome.
Franks S; Stark J; Hardy K
Hum Reprod Update; 2008; 14(4):367-78. PubMed ID: 18499708
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and features of the polycystic ovary syndrome in an unselected population.
Azziz R; Woods KS; Reyna R; Key TJ; Knochenhauer ES; Yildiz BO
J Clin Endocrinol Metab; 2004 Jun; 89(6):2745-9. PubMed ID: 15181052
[TBL] [Abstract][Full Text] [Related]
11. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
Rosenfield RL; Ehrmann DA
Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
[TBL] [Abstract][Full Text] [Related]
12. Heritability of polycystic ovary syndrome in a Dutch twin-family study.
Vink JM; Sadrzadeh S; Lambalk CB; Boomsma DI
J Clin Endocrinol Metab; 2006 Jun; 91(6):2100-4. PubMed ID: 16219714
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.
Legro RS; Kunselman AR; Dodson WC; Dunaif A
J Clin Endocrinol Metab; 1999 Jan; 84(1):165-9. PubMed ID: 9920077
[TBL] [Abstract][Full Text] [Related]
14. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
Azziz R; Carmina E; Dewailly D; Diamanti-Kandarakis E; Escobar-Morreale HF; Futterweit W; Janssen OE; Legro RS; Norman RJ; Taylor AE; Witchel SF;
Fertil Steril; 2009 Feb; 91(2):456-88. PubMed ID: 18950759
[TBL] [Abstract][Full Text] [Related]
15. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.
Kiddy DS; Hamilton-Fairley D; Bush A; Short F; Anyaoku V; Reed MJ; Franks S
Clin Endocrinol (Oxf); 1992 Jan; 36(1):105-11. PubMed ID: 1559293
[TBL] [Abstract][Full Text] [Related]
16. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.
Caglar GS; Kahyaoglu I; Pabuccu R; Demirtas S; Seker R
Arch Gynecol Obstet; 2013 Oct; 288(4):905-10. PubMed ID: 23553200
[TBL] [Abstract][Full Text] [Related]
17. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.
Escobar-Morreale HF
Nat Rev Endocrinol; 2018 May; 14(5):270-284. PubMed ID: 29569621
[TBL] [Abstract][Full Text] [Related]
18. Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.
Dewailly D; Robin G; Peigne M; Decanter C; Pigny P; Catteau-Jonard S
Hum Reprod Update; 2016 Nov; 22(6):709-724. PubMed ID: 27566840
[TBL] [Abstract][Full Text] [Related]
19. Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion.
Cimino I; Casoni F; Liu X; Messina A; Parkash J; Jamin SP; Catteau-Jonard S; Collier F; Baroncini M; Dewailly D; Pigny P; Prescott M; Campbell R; Herbison AE; Prevot V; Giacobini P
Nat Commun; 2016 Jan; 7():10055. PubMed ID: 26753790
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, diagnosis, and management of polycystic ovary syndrome.
Sirmans SM; Pate KA
Clin Epidemiol; 2013 Dec; 6():1-13. PubMed ID: 24379699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
